The ballots are counted, the run-off elections are complete, and a new administration and Congress are set to begin. You may recall that the mock election that was held during the 2008 Annual Scientific Meeting—78% of U.S. meeting attendees chose Barack Obama as their next president—and the general election echoed that choice. On January 20, Barack Obama was sworn in as the United States’ 44th President.
Fibromyalgia
Patient Fact Sheet
In America’s Recession, the REF Remains Strong
According to a survey conducted in October 2008 by the Washington Regional Association of Grantmakers, three-quarters of the region’s leading foundations and corporate giving programs suffered a decline in assets because of plummeting returns on investments over 2008. About one-third of the respondents said they reduced grant budgets from 2007 to 2008, and about half of the organizations said they plan to award fewer grants in 2009.
State-of-the-Art Clinical Symposium: New Offerings, Returning Favorites
If you are looking for a CME symposium that will present up-to-date, cutting-edge information on a broad array of topics in rheumatology in an intimate setting, you won’t want to miss the 2009 ACR State-of-the-Art Clinical Symposium held Friday, April 17–Sunday, April 18 in Chicago, Ill.
Electronic Prescribing: The First Step Towards an Integrated Health Delivery System?
With the introduction of the 2009 Centers for Medicare and Medicaid Services’ (CMS’s) electronic prescribing incentive program, the door is opening for widespread adoption of health information technology (HIT) within the physician’s practice.
Measuring Quality of Care Is Here to Stay—and the ACR Can Help
Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.
Biologic Logic: Making Sense of Current Therapies for Rheumatic Diseases
Continuing the ARHP 2009 Audioconference/Webcast series, Daniel F. Battafarano, DO, FACP, FACR, will discuss the use of biologic therapy in the treatment of rheumatology patients on February 10 from noon to 1:00 pm ET. During the session, Dr. Battafarano will review basic immunology, inflammation, and relevant cytokines for common rheumatic diseases. In addition, he will describe the current biologic therapies and their relationship to rheumatic disease outcomes, and identify future biologic strategies for therapy.
The Language of Lawmaking
Many people shy away from participating in advocacy efforts because they are uncomfortable with the terminology used.
Juvenile Idiopathic Arthritis
Patient Fact Sheet
ARHP Presidential Introduction
As the newly minted president of the ARHP, I’d like to introduce myself.
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 134
- Next Page »